| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9451 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8918 |
| P-glycoprotein Substrate | Substrate | 0.6937 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6917 |
| Non-inhibitor | 0.9113 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7501 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5425 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8402 |
| CYP450 2D6 Substrate | Non-substrate | 0.8948 |
| CYP450 3A4 Substrate | Substrate | 0.7593 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7389 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9327 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9268 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7832 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8505 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7223 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8493 |
| Non-inhibitor | 0.6626 |
| AMES Toxicity | Non AMES toxic | 0.9194 |
| Carcinogens | Non-carcinogens | 0.9370 |
| Fish Toxicity | High FHMT | 0.9612 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8856 |
| Honey Bee Toxicity | High HBT | 0.8283 |
| Biodegradation | Not ready biodegradable | 0.9606 |
| Acute Oral Toxicity | III | 0.5729 |
| Carcinogenicity (Three-class) | Non-required | 0.4138 |